PatientsLikeMe taps social network for trials recruitment

With drug developers seeking online methods to streamline patient recruitment for clinical trials, PatientsLikeMe is rolling out a new service on its social networking website that automatically provides its members with info on appropriate studies for them via data from The Cambridge, MA-based firm also reports today that developers can send emails to its patient members--without knowing their identities--to invite them to participate in a clinical trial. "This opens up access for companies to target their outreach to the right patients," Jamie Heywood, co-founder and chairman of PatientsLikeMe, said in a statement. "Together, we can make trial enrollment faster, more efficient and more accessible to the people that need them--patients." Story

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.